Raloxifene for Women With Alzheimer's Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dr Victor Henderson
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Permanente Santa Rosa
Santa Rosa, California, United States
- Stanford University School of Medicine
Stanford, California, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- Indiana University Medical Center
Indianapolis, Indiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2006
- Primary completion
- 31 Mar 2011
- Completion
- 31 Jan 2012
- Last update posted
- 2 Apr 2015
- Registered enrollment
- 42
- Registry id
- NCT00368459
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.